Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04329455
Other study ID # Ahmed1989
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 1, 2020
Est. completion date April 1, 2023

Study information

Verified date March 2020
Source Assiut University
Contact Ahmed Mohamed Gamal, MD
Phone 01069850499
Email ahmedgamalgeneralsurgery@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Evaluation of Endoscopic Thyroidectomy via Axillo-breast Approach in Thyroid Nodules regarding safety and cosmetic outcomes


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date April 1, 2023
Est. primary completion date April 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- benign thyroid nodules unilateral or bilateral Normal thyroid function

Exclusion Criteria:

- malignant Thyroid Nodules Recurrent goitre Toxic goitre

Study Design


Related Conditions & MeSH terms

  • Safety and Cosmetic Issues in Endoscopic Thyroidectomy
  • Thyroid Nodule

Intervention

Procedure:
Endoscopic thyroidectomy
Endoscopic thyroidectomy in Thyroid Nodules

Locations

Country Name City State
Egypt Ahmed Gamal Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Safety of Endoscopic Thyroidectomy 2020_2023
Secondary Cosmetic outcome of Endoscopic Thyroidectomy 2020_2023